Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Treat index level as a practical tool to guide trades, enabling more consistent setups and disciplined execution across markets.
20,888 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Budget models warn that trump’s strikes iran could carry a heavy price tag for taxpayers and households, with direct ...
U.S. forces say they destroyed 16 Iranian minelayers, signaling a flare-up near the Strait of Hormuz. Markets react a...
A new heavyweight in crypto treasuries is nearing a public listing. Evernorth, with a sizable XRP stash, aims to rede...
Prospect Capital offers a striking 20%+ yield, but its long-run performance raises questions. This article lays out a...
Rocket Lab delivers a record quarter that lights up the stock market today. This deep dive explains the rally, the ba...
As the Dow breaks above 50,000 in early 2026, investors revisit the ghost 36,000 milestone and debate whether old bet...
Investors have watched quantum stocks climb even amid mixed news. This guide explains the forces fueling the rally, h...
A sweeping proposal from former President Donald Trump and ex-Fed official Kevin Warsh would dramatically increase So...
A stronger-than-expected jobs report unleashed a broad market selloff, wiping $1.4 trillion from S&P 500 valuations a...
In 2026, investors face a choice between a nimble biotech player and a global pharma titan. This guide compares Lexic...
A leading market strategist argues the AI-led pullback is routine profit-taking after a rapid rally, with the AI infr...